Tranquis Therapeutics
PrivateLast Round
Series A
Jul 9, 2020
Total Funding Raised
$30M
Company Overview
Tranquis Therapeutics is a biopharmaceutical company focused on developing innovative small molecule drugs that reprogram dysfunctional myeloid immune cells to transform the treatment of neurodegenerative and aging-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tranquis Therapeutics Comparables
Compare Tranquis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Monument Biosciences | 86% | |
| NeuroTherapia, Inc. | 86% | |
| Muna Therapeutics | 82% |
Tranquis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 9, 2020 |
Tranquis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Remiges Ventures | Series A |
| Correlation Ventures | Series A |
| SR One | Series A |
| Vivo Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 9, 2020
$30M round led by Remiges Ventures and SR One.
Tranquis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tranquis Therapeutics's valuation, stock price, and market status.
Is Tranquis Therapeutics a public or private company?
Tranquis Therapeutics is a private company.
What is the current stock price of Tranquis Therapeutics?
Tranquis Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Tranquis Therapeutics worth (valuation)?
Valuation information for Tranquis Therapeutics is not publicly available.
Can I buy Tranquis Therapeutics stock?
Tranquis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tranquis Therapeutics's last funding round?
Tranquis Therapeutics's most recent funding round was Series A on July 9, 2020.
Who are the main investors in Tranquis Therapeutics?
Key investors in Tranquis Therapeutics include Remiges Ventures, SR One.
Will Tranquis Therapeutics IPO soon?
No public IPO plans have been announced for Tranquis Therapeutics.
How can I track Tranquis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tranquis Therapeutics's secondary market activity and sign up for updates.